Intestinal Research
Scope & Guideline
Advancing the Frontiers of Gastroenterology
Introduction
Aims and Scopes
- Investigation of Inflammatory Bowel Diseases (IBD):
The journal consistently publishes research on the clinical characteristics, treatment approaches, and long-term outcomes of IBD, particularly Crohn's disease and ulcerative colitis. - Clinical Trials and Real-World Studies:
There is a strong emphasis on both randomized controlled trials and real-world observational studies that evaluate the efficacy and safety of various therapies for IBD, including biologics and small molecules. - Innovative Diagnostic Approaches:
The journal highlights studies utilizing advanced imaging techniques, biomarkers, and endoscopic methods to improve diagnosis and monitoring of gastrointestinal diseases. - Multidisciplinary Perspectives:
Research often incorporates insights from gastroenterology, immunology, nutrition, and surgery, reflecting a holistic approach to managing gastrointestinal disorders. - Focus on Asian Populations:
A significant portion of the research addresses the unique clinical characteristics and treatment responses in Asian populations, contributing valuable data to the global understanding of IBD.
Trending and Emerging
- Biomarkers and Precision Medicine:
An increasing number of studies focus on identifying biomarkers that predict treatment response and disease progression, suggesting a trend towards precision medicine in managing IBD. - Impact of Gut Microbiota:
Research exploring the role of gut microbiota in IBD pathogenesis, treatment response, and overall health is gaining momentum, indicating a growing interest in microbiome-targeted therapies. - Mental Health and Quality of Life:
There is a rising emphasis on the psychosocial aspects of living with IBD, including mental health issues and quality of life assessments, reflecting a holistic approach to patient care. - COVID-19 and IBD Patients:
Research examining the effects of COVID-19 on patients with IBD has emerged as a significant theme, particularly regarding vaccination impacts and disease management during the pandemic. - New Therapeutic Agents:
The exploration of novel therapeutic agents, including JAK inhibitors and other small molecules, is becoming increasingly prevalent, as researchers seek to expand treatment options for refractory cases.
Declining or Waning
- Traditional Medical Therapies:
There is a noticeable decline in studies focusing exclusively on traditional medical therapies like corticosteroids, as newer treatment options such as biologics and small molecules gain prominence. - Basic Science Research:
The journal has shifted its focus away from purely basic science studies, particularly those that do not directly translate into clinical practice or patient outcomes. - Epidemiological Studies:
While still present, there appears to be a decrease in the publication of broad epidemiological studies related to IBD, possibly due to an increased emphasis on targeted clinical trials and specific therapeutic interventions. - Single-Center Studies:
There is a diminishing trend in the publication of single-center studies, as the journal increasingly favors multicenter collaborations that offer broader data and more robust conclusions. - Case Reports:
The frequency of case reports has declined, likely due to a preference for studies that provide larger datasets and more generalizable findings.
Similar Journals
Minerva Gastroenterology
Exploring New Frontiers in Digestive Health ResearchMinerva Gastroenterology, published by EDIZIONI MINERVA MEDICA, is a notable academic journal dedicated to advancing the field of gastroenterology and related disciplines. With an ISSN of 2724-5985 and an E-ISSN of 2724-5365, this journal gathers innovative research from diverse areas including internal medicine, endocrinology, and metabolism. Though characterized by its open-access policies, Minerva Gastroenterology aims to provide a platform for high-quality scholarly articles with an emphasis on critical reviews, clinical studies, and translational research. Since its inception in 2021, the journal has managed to secure a reputation reflected in its Q3 rank across multiple categories in 2023, as well as its standing in Scopus rankings, positioning it in the 45th to 47th percentile among renowned medical journals. Situated in Turin, Italy, it fosters collaboration and knowledge-sharing among researchers and practitioners, making it an essential resource for those seeking to deepen their understanding of gastroenterological conditions and enhance clinical practices.
Gastroenterology
Leading the Way in Gastrointestinal Research ExcellenceGastroenterology, published by W B Saunders Co-Elsevier Inc, is a premier journal dedicated to advancing the knowledge and practice within the fields of gastroenterology and hepatology. Established in 1945 and covering a wide range of topics related to digestive health, this journal holds a distinguished position in the academic community, as evidenced by its impressive Q1 status in both Gastroenterology and Hepatology categories, and its high rankings (4th in both disciplines) in Scopus, placing it in the top percentile for scholarly impact. With its commitment to publishing high-quality research, reviews, and clinical studies, Gastroenterology provides an essential resource for researchers, healthcare professionals, and students seeking cutting-edge insights that inform clinical practices and enhance patient care. Although it does not currently offer open access, the journal continues to serve as a vital platform for disseminating meaningful research that shapes the future of digestive disease management.
ACTA GASTRO-ENTEROLOGICA BELGICA
Elevating Clinical Insights for Optimal Patient OutcomesACTA GASTRO-ENTEROLOGICA BELGICA is a prestigious journal dedicated to advancing the field of gastroenterology through the dissemination of high-quality research and clinical insights. Published by UNIVERSITE CATHOLIQUE DE LOUVAIN (UCL), this journal is an essential resource for researchers, healthcare professionals, and students alike, focusing on a wide range of topics including gastrointestinal diseases, treatments, and innovations in clinical practices. While the journal operates under a traditional access model, its impact in the academic community is significant, ensuring that vital research is communicated effectively to stakeholders in Belgium and beyond. With its commitment to academic excellence, ACTA GASTRO-ENTEROLOGICA BELGICA plays a crucial role in fostering high-level discourse and collaboration among experts in the field, ultimately encouraging advancements that improve patient care and outcomes.
Crohns & Colitis 360
Championing collaboration in Crohn's and colitis research.Crohns & Colitis 360, published by Oxford University Press, is a leading open access journal that has been at the forefront of gastrointestinal research since its launch in 2019. With an E-ISSN of 2631-827X, this journal aims to foster innovation and collaboration within the field of gastroenterology, focusing on diseases such as Crohn's disease and ulcerative colitis. As of 2023, it has earned a commendable Q2 ranking in the gastroenterology category, positioning it among the top 50% of journals in its field, with a Scopus rank of 99 out of 167. Crohns & Colitis 360 not only provides a platform for peer-reviewed research but also seeks to disseminate clinical guidelines, reviews, and groundbreaking studies, making it an essential resource for researchers, healthcare professionals, and students dedicated to advancing the understanding and treatment of inflammatory bowel diseases. Emphasizing accessibility, the journal has been open access since its inception, ensuring that cutting-edge research is readily available to a global audience. This commitment to knowledge sharing significantly enhances its impact and relevance in the ever-evolving landscape of gastroenterology.
Pediatric Gastroenterology Hepatology & Nutrition
Advancing pediatric health through innovative research.Pediatric Gastroenterology Hepatology & Nutrition is a pivotal academic journal published by the Korean Society of Pediatric Gastroenterology & Nutrition, focusing on the critical fields of pediatric gastroenterology, hepatology, and nutrition. Located in South Korea, this journal aims to disseminate high-quality research, review articles, and clinical studies to advance knowledge and practice in the care of children with gastrointestinal and nutritional disorders. With a Converged Years span from 2012 to 2024 and categorized in the Q2 and Q3 quartiles in 2023 across multiple related fields, the journal holds a significant position within the academic community, reflecting its impactful contribution to the discipline. Although currently not open access, the journal ensures that content is accessible to a broad audience through various institutional subscriptions. The journal appeals to researchers, healthcare professionals, and students alike, providing an essential platform for the exchange of innovative ideas and research findings aimed at improving pediatric patient care.
DISEASES OF THE COLON & RECTUM
Discovering Solutions for Colorectal ChallengesDISEASES OF THE COLON & RECTUM, published by Lippincott Williams & Wilkins, stands as a critical resource in the field of gastroenterology, focusing on the comprehensive study and management of colorectal diseases. With an ISSN of 0012-3706 and an E-ISSN of 1530-0358, this journal serves a diverse audience, including researchers, clinicians, and students interested in the latest advancements in this vital area of medicine. Recognized for its quality, it holds a Q2 ranking in both Gastroenterology and Miscellaneous Medicine categories for 2023 and is positioned at the 58th percentile within its Scopus rank. Since its inception in 1958, the journal has dedicated itself to disseminating original research, reviews, and clinical studies, providing a platform for sharing innovative findings that drive the field forward. While it is not an open access journal, its content remains pivotal for professionals looking to stay apprised of evidence-based practices and emerging trends in colorectal health. With ongoing contributions expected until 2024, DISEASES OF THE COLON & RECTUM continues to be an indispensable source of knowledge for anyone engaged in the intricacies of digestive health.
DIGESTIVE DISEASES AND SCIENCES
Advancing knowledge in digestive health.DIGESTIVE DISEASES AND SCIENCES, a renowned journal published by Springer, plays a pivotal role in advancing the fields of gastroenterology and physiology. With a rich publication history spanning from 1979 to 2024, this journal not only holds an impressive Q1 ranking in both categories but also ranks 34th out of 167 in Gastroenterology and 60th out of 193 in Physiology according to Scopus, reflecting its significant impact and reputation within the academic community. Despite being a traditional journal without open access options, it remains a crucial platform for researchers, professionals, and students seeking to disseminate their findings and stay abreast of the latest developments in digestive health. The journal is accessible to a global audience and is dedicated to publishing high-quality, peer-reviewed research, making it an invaluable resource for anyone involved in the study or treatment of digestive diseases.
Translational Gastroenterology and Hepatology
Advancing Patient Outcomes through Translational Research.Translational Gastroenterology and Hepatology, published by AME Publishing Company, stands as a pivotal platform for advancing the understanding and treatment of gastrointestinal and liver diseases. With its focus on translational research, this journal aims to bridge the gap between laboratory discoveries and clinical applications, thus fostering improvements in patient care. Although specific metrics like H-Index and Scopus ranks are currently unavailable, the journal is committed to maintaining high standards of scholarly communication and excellence. As an open-access publication, it ensures that valuable findings are readily accessible to a global audience, promoting collaboration and innovation among researchers, clinicians, and healthcare professionals invested in gastroenterology and hepatology. The journal's dedication to disseminating groundbreaking research makes it an essential resource for those seeking to stay at the forefront of these ever-evolving fields.
WORLD JOURNAL OF GASTROENTEROLOGY
Championing high-quality studies in gastroenterology.WORLD JOURNAL OF GASTROENTEROLOGY, published by BAISHIDENG PUBLISHING GROUP INC, stands at the forefront of gastrointestinal research, providing a critical platform for the dissemination of high-quality studies in the field. With an impressive impact factor reflected in its Q1 rankings in both Gastroenterology and Miscellaneous Medicine, this journal is recognized for its rigorous peer-review process and commitment to advancing knowledge and practices related to digestive health. Covering comprehensive scopes from clinical advancements to innovative therapies, the journal serves an essential role for researchers, clinicians, and students, enabling them to stay updated on the latest developments and findings from 1998 through 2024. The open access model facilitates broader accessibility, ensuring that groundbreaking research reaches a global audience. The journal's ranking within the top 15% of Scopus demonstrates its significant contribution to the academic community, making it a valuable resource for advancing the science of gastroenterology.
Frontline Gastroenterology
Elevating Knowledge in Gastroenterology and HepatologyFrontline Gastroenterology is a leading academic journal published by the BMJ Publishing Group that plays a vital role in advancing the field of gastroenterology and hepatology. Established in 2013, this prestigious journal has established itself as a significant resource for researchers, healthcare professionals, and students alike, maintaining a commendable impact factor and consistently achieving a Q2 ranking in both gastroenterology and hepatology categories as of 2023. With its focus on disseminating high-quality, peer-reviewed research, Frontline Gastroenterology covers a wide scope of topics pertinent to the understanding, diagnosis, and treatment of gastrointestinal and liver diseases. Although it does not offer Open Access options, its content is accessible through various institutional and personal subscriptions, ensuring that critical findings reach an international audience. As the journal continues to converge into the future, it remains dedicated to fostering innovation and dialogue in gastroenterological sciences.